Related content

Synergistic Efficacy in Human Ovarian Cancer Cells by Histone Deacetylase Inhibitor TSA and Proteasome Inhibitor PS-341

By Fang Yong   Hu Yi   Wu Peng   Wang Beibei   Tian Yuan   Xia Xi   Zhang Qinghua   Chen Tong   Jiang Xuefeng   Ma Quanfu   Xu Gang   Wang Shixuan   Zhou Jianfeng   Ma Ding   Meng Li  

Cancer Investigation, Vol. 29, Iss. 4, 2011-04 ,pp. : 247-252

Informa Healthcare

Access to resources Recommend Favorite

The Interaction of Histone Deacetylase Inhibitors and DNA Methyltransferase Inhibitors in the Treatment of Human Cancer Cells

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 3, Iss. 3, 2003-05 ,pp. : 187-199

Bentham Science Publishers

Access to resources Recommend Favorite

Histone Deacetylase Inhibitors and Colorectal Cancer: what is new?

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 9, 2014-11 ,pp. : 1220-1227

Bentham Science Publishers

Access to resources Recommend Favorite

A Novel Histone Deacetylase Inhibitor, Scriptaid, Enhances Expression of Functional Estrogen Receptor α (ER) in ER negative human breast cancer cells in combination with 5-aza 2′-deoxycytidine

By Keen J.C.   Yan L.   Mack K.M.   Pettit C.   Smith D.   Sharma D.   Davidson N.E.  

Breast Cancer Research and Treatment, Vol. 81, Iss. 3, 2003-10 ,pp. : 177-186

Springer Publishing Company

Access to resources Recommend Favorite

Pro-apoptotic activity of oncogenic H-Ras for histone deacetylase inhibitor to induce apoptosis of human cancer HT29 cells

By Choudhary Shambhunath   Wang Hwa-Chain  

Journal of Cancer Research and Clinical Oncology, Vol. 133, Iss. 10, 2007-10 ,pp. : 725-739

Springer Publishing Company

Access to resources Recommend Favorite